Invitrogen offers many insightful publications throughout the year. Enhance your research with BioPath Online™, BioProbes® and ProbesOnline™
Pathway Focus: The AKT Pathway
Currently, Akt and its pathway are one of the most actively studied kinases and kinase pathways in basic research and drug development. Activated Akt is a key signaling mediator for cell growth, cell survival (anti-apoptosis), cell-cycle progression, differentiation, transcription, translation, and glucose metabolism.
Get accurate quantitation of 7 AKT pathway proteins with the AKT Total and Phospho 7-Plex Panel, exclusively from Invitrogen. This panel can detect protein levels, needs only a small sample, and can be run in ~4 hr. Validation includes bead and protein specificity, precision, intra- and inter-assay of <10%, parallelism between recombinant and natural samples, linearity of dilution, recovery (>80%), and comparison to ELISA (>90%). Premixed multiplex kits include General Buffer Reagent Kit and Antibody Bead Kit components, with reagents premixed for the number of markers.
|Product||Species||Markers|| Cat. No.|
|Akt Pathway Phospho 7-Plex Panel||Human, mouse, rat||Akt [pS473], GSK-3β [pS9], IRS-1 [pS312], IGF-1R [pYpY1135/1136], IR [pYpY1162/1163], p70S6K [pTpS421/424], PRAS40 [pT246]||LHO0001|
|Akt Pathway Total 7-Plex Panel||Human, mouse, rat||Akt, GSK-3β, IGF-1R, IR, IRS-1, p70S6K, PRAS40||LHO0002|
Platelet-derived growth factor (PDGF) contributes to cell survival, movement, proliferation, angiogenesis, etc. Two classical growth factors in the PDGF family are PDGF-A and PDGF-B, active as homodimers and as the heterodimer PDGF-AB. Active growth factors bind to two receptors, PDGFR-α and PDGFR-β.
|Once bound, the receptors lead to activation of various pathways associated with receptor tyrosine kinase signaling, including the Akt pathway. Upon receptor activation, PI3K interacts with the receptor and activates Akt, promoting downstream events.|
Invitrogen offers recombinant PDGF-AA, PDGF-BB, and PDGF-AB to facilitate Akt pathway activation. In addition, we offer other growth factors to study Akt signaling.
Learn more at www.invitrogen.com/proteins
Figure 1. Immunofluorescence staining. Serum-starved NIH3T3 cells left untreated (left) or treated with PDGF (right) were fixed prior to immunostaining with the Akt [pS473] rabbit monoclonal antibody.The signal was detected with an anti-rabbit FITC-conjugated secondary antibody. The data show that the antibody detected phosphorylated Akt in PDGF-treated NIH3T3 cells. Cells were counterstained with DAPI.
AKT can be activated by a diverse array of growth factors and physiologic stimuli in a PI3K–dependent manner. Activated Akt affects downstream markers such as 4E-BP1, p70-S6K, and PRAS40, and acts as a key mediator of signals for cell survival, proliferation, angiogenesis, and a number of metabolic effects of insulin.
Eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is an important effector of mTOR signaling. Hypophosphorylated 4E-BP1 acts as a translational repressor by binding and inhibiting the eIF4E.
|Proline-rich Akt substrate of 40 kDa (PRAS40) is a direct substrate for AKT. |
Invitrogen™ sandwich ELISA kits quickly detect and quantify site-specific phosphoproteins in cell lysates. Total kits normalize the protein content of the sample, independent of the phosphorylation state. ELISA kits allow for high throughput of samples in a 96-well format and get quantitative results reproducibly. Calibrated protein standards allow quantification in each experimental run. Using these tools together, you’ll gain a more detailed understanding of signaling proteins in the Akt pathway.
p70 ribosomal protein S6 kinase (p70-S6K) is a member of the ribosomal S6 kinase (RSK) family of serine/threonine kinases. The primary pathway by which most growth factors and cytokines activate p70-S6K appears to be the PI3K Akt-mTOR pathway.
|Description||Species ||Size||Cat. No.|
|Akt [pS473] ELISA Kit ||Hu, Ms, Rt ||96 tests ||KHO0111|| |
|Akt (Total) ELISA Kit ||Hu, Ms, Rt ||96 tests ||KHO0101|
|4E-BP1 [pT46] ||Hu, Ms, Rt ||96 tests ||KHO0691|
|4E-BP1 (Total) ELISA Kit ||Hu, Ms, Rt ||96 tests ||KHO0681|
|P70-S6K [pT389] ELISA Kit ||Hu, Ms, Rt ||96 tests ||KHO0581|
|P70-S6K (Total) ELISA Kit ||Hu, Ms, Rt ||96 tests ||KHO0571|
|PRAS40 [pT246] ELISA Kit||Hu ||96 tests ||KHO0421|
|PRAS40 (Total) ELISA Kit||Hu ||96 tests ||KHO0411|
ABfinity™ antibodies are the next generation of antibodies, exclusively from Invitrogen. They are generated by cloning specific genes of antibodies, and then producing them in a mammalian expression system. With the help of ABfinity™ technology, we've generated the most specific antibodies to generate highly reproducible results.
Abnormalities in the PI3K/Akt cascading signaling pathway are associated with cancer, diabetes, cardiovascular conditions, neurological disorders, and other diseases. Developing effective treatments has required altering the activity of this pathway.
|To help scientists looking at Akt signal transduction, we offer the Akt [pS473] ABfinity™ Recombinant Rabbit Monoclonal Antibody to study the effects of Akt cell signaling in glucose metabolism, cell cycle, cell survival, adhesion, and angiogenesis. All antibodies are tested against multiple species and with all major applications. In addition, we have the best portfolio of phosphorylation site-specific and total antibodies. Invitrogen is the only company to test each lot of phosphorylation site-specific antibodies with peptide competition, to make sure each lot detects only at the right site.|
Flow cytometry of Jurkat cells labeled with rabbit anti-Akt [pS473]. Jurkat cells were incubated with 50 µM LY294002 (red trace) or without (green trace) for 1 hr prior to being fixed and permeabilized using FIX&PERM® reagents. Cells were then stained with 1 μg Akt [pS473] followed by Alexa Fluor® 488 goat anti-rabbit IgG. Blue trace represents secondary antibody alone.
Immunocytochemistry of mouse fibroblasts cells labeled with rabbit anti-Akt [pS473]. Mouse fibroblast cells were treated with (top right) or without (top left) insulin and labeled with rabbit anti-Akt [pS473]. Signal is knocked down after incubation with the phosphopeptide used as an immunogen (bottom left), but not with the non-phosphopeptide (bottom right). Alexa Fluor® 488 goat anti-rabbit IgG was used as secondary antibody. Nuclei are stained with Hoechst (blue).
Immunohistochemistry of human esophagus carninoma tissue labeled with rabbit anti-Akt [pS473]. PE human esophagus carcinoma tissue was labeled with rabbit anti-Akt [pS473]. Tissues were pretreated with EDTA and detected with SuperPicTure™ Polymer DAB. Note nuclear and cytoplasmic staining in tumor cells.
Western blot of 3T3 lysates labeled with rabbit anti-Akt [pS473]. Rabbit anti-Akt [pS473] was used to label Akt [pS473] in untreated 3T3 lysates (lane 1) or PDGF-treated 3T3 lysates (lane 2).
|Description||Reactivity: Tested (Predicted)||Applications||Size||Cat. No.|
|PKC-θ [pT538] ABfinity™ Recombinant Rabbit Monoclonal Antibody||Hu (X, Rt, Ms, Cp, B)||WB,F, IHC, IF/ICC||100 μg||700043|
|Mnk1 [pT197/pT202] ABfinity™ Recombinant Rabbit Monoclonal Antibody||Hu (Z, X, Sw, Rt, P, Ms, Mk (Rh), Eq, Eq, Cp, Ch, Cn, B)||WB,F, IF/ICC||100 μg||700242|
|Cul-2 ABfinity™ Recombinant Rabbit Monoclonal Antibody||Hu, Rt, Ms (X, Or, Mk (Rh), Eq, Cp, Cn, B)||WB,F, IHC, IF/ICC||100 μg||700179|
|IRAK4 ABfinity™ Recombinant Rabbit Monoclonal Antibody||Hu (Sw, Sh, Rt, Qu, Eq, Cn, B)||F, IF/ICC||100 μg||700026|
|AMPKβ1 [pS182] ABfinity™ Recombinant Rabbit Monoclonal Antibody||Hu (X, Rt, Or, Eq, Ch, Cn, B, Ms)||WB,F, IHC, IF/ICC||100 μg||700241|
|Smad1/5 [pS463/pS465] ABfinity™ Recombinant Rabbit Monoclonal Antibody||Hu (Z, X, Sw, Sh, Su, Rt, Ms, Mk (Rh), Eq, Cp, Ch, Cn, B)||F, IHC, IF/ICC||100 μg||700047|
|4E-BP1 [pT37] ABfinity™ Recombinant Rabbit Monoclonal Antibody||Hu (Z, Rt, Ms, B, Hu, Eq)||E, WB,F, IHC, IF/ICC||100 μg||700238|
|STAT4 ABfinity™ Recombinant Rabbit Monoclonal Antibody||Hu, Ms, Rt (Sw, Eq)||E, WB,F, IHC, IF/ICC||100 μg||700185|
|SUMO-3 ABfinity™ Recombinant Rabbit Monoclonal Antibody||Hu, Ms, Rt (Mk (Rh), Cp)||WB,F, IHC, IF/ICC||100 μg||700186|
|CASP3 [D175] ABfinity™ Recombinant Rabbit Monoclonal Antibody (clone 9H19L2)||Hu (X, Sw, Sh, Rt, Rabbit, P, Ms, Eq, Ha, Fe, Eq, Cp, Cn, B)||E, WB,F, IHC, IF/ICC||100 μg||700182|
The Premo™ FUCCI cell cycle sensor enables live-cell imaging—as cells progress through the cell cycle, nuclear fluorescence changes from red to yellow to green.
|In 2008, Miyawaki and colleagues developed the Fluorescent Ubiquitination-based Cell Cycle Indicator (FUCCI), a fluorescent protein (FP)–based sensor that employs red (RFP) and green (GFP) fluorescent proteins fused to different regulators of the cell cycle, Cdt1 and geminin. The Premo™ FUCCI Cell Cycle Sensor takes this technology one step further by using the BacMam gene delivery system—the prepackaged genetically-encoded reagents are ready for immediate use. Simply add the Premo™ FUCCI reagents to your cells, treat with the BacMam enhancer, wash, incubate overnight for protein expression, and visualize cell cycle progression using fluorescence microscopy.|
Akt plays various roles in cell cycle progression. With the Premo™ FUCCI Cell Cycle Sensor, researchers can accurately and easily visualize cell cycle progression in live cells.
|Live-cell imaging with Premo™ FUCCI Cell Cycle Sensor. U2OS cells treated were transduced with the Premo™ FUCCI Cell Cycle Sensor and co-stained with the far red-fluorescent Alexa Fluor® 647 wheat germ agglutinin. Imaging was performed on live cells using a Delta Vision Core microscope and standard FITC/TRITC/Cy5 filter sets.|